Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 414

1.

Investigating Race and Gender in Age at Onset of Hidradenitis Suppurativa.

Morss PC, Porter ML, Savage KT, Rosales Santillan M, Giannotti N, Kimball AB.

J Eur Acad Dermatol Venereol. 2019 Nov 17. doi: 10.1111/jdv.16095. [Epub ahead of print]

PMID:
31736152
2.

Mutational Landscape of Grey Zone Lymphoma.

Sarkozy C, Hung S, Takata K, Chavez E, Aoki T, Duns G, Slack GW, Telenius A, Miyata-Takata T, Viganò E, Molina TJ, Damotte D, Ben-Neriah S, Copie-Bergman C, Laurent C, Mottok A, Salles G, Savage KJ, Scott DW, Traverse-Glehen A, Steidl C.

Blood. 2019 Nov 13;134(Supplement_1):21. doi: 10.1182/blood-2019-127375.

PMID:
31724008
3.

S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.

Sarris J, Murphy J, Stough C, Mischoulon D, Bousman C, MacDonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng CH, Byrne GJ.

Psychopharmacology (Berl). 2019 Nov 11. doi: 10.1007/s00213-019-05358-1. [Epub ahead of print]

PMID:
31712971
4.

Dentine hypersensitivity and associated factors: a Nigerian cross-sectional study.

Savage KO, Oderinu OH, Oginni AO, Uti OG, Adegbulugbe IC, Dosumu OO.

Pan Afr Med J. 2019 Jul 30;33:272. doi: 10.11604/pamj.2019.33.272.18056. eCollection 2019.

5.

Simultaneous numerical representation of soil microsite production and consumption of carbon dioxide, methane, and nitrous oxide using probability distribution functions.

Sihi D, Davidson EA, Savage KE, Liang D.

Glob Chang Biol. 2019 Oct 3. doi: 10.1111/gcb.14855. [Epub ahead of print]

PMID:
31580516
6.

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.

Tobin JWD, Rule G, Colvin K, Calvente L, Hodgson D, Bell S, Dunduru C, Gallo J, Tsang ES, Tan X, Wong J, Pearce J, Campbell R, Tneh S, Shorten S, Ng M, Cochrane T, Tam CS, Abro E, Hawkes E, Hodges G, Kansara R, Talaulikar D, Gilbertson M, Johnston AM, Savage KJ, Villa D, Morris K, Ratnasingam S, Janowski W, Kridel R, Cheah CY, MacManus M, Matigian N, Mollee P, Gandhi MK, Hapgood G.

Blood Adv. 2019 Oct 8;3(19):2804-2811. doi: 10.1182/bloodadvances.2019000458.

7.

Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.

Amador C, Greiner TC, Heavican TB, Smith LM, Galvis KT, Lone WG, Bouska A, D'amore F, Bjerregård Pedersen M, Pileri SA, Agostinelli C, Feldman AL, Rosenwald A, Ott G, Mottok A, Savage KJ, de Leval L, Gaulard P, Lim ST, Ong CK, Ondrejka SL, Song J, Campo E, Jaffe ES, Staudt LM, Rimsza LM, Vose J, Weisenburger DD, Chan WC, Iqbal J.

Blood. 2019 Sep 27. pii: blood.2019000779. doi: 10.1182/blood.2019000779. [Epub ahead of print]

PMID:
31562134
8.

Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.

Jin A, Pousti BT, Savage KT, Mollanazar NK, Lee JB, Hsu S.

JAAD Case Rep. 2019 Aug 30;5(9):815-817. doi: 10.1016/j.jdcr.2019.07.026. eCollection 2019 Sep. No abstract available.

9.

Genetic basis for skin youthfulness.

Flood KS, Houston NA, Savage KT, Kimball AB.

Clin Dermatol. 2019 Jul - Aug;37(4):312-319. doi: 10.1016/j.clindermatol.2019.04.007. Epub 2019 Apr 26.

PMID:
31345318
10.

Educational, Psychosocial and Protection Outcomes of Child- and Youth-Focused Programming with Somali Refugees in Buramino Camp, Dollo Ado, Ethiopia.

Metzler J, Jonfa M, Savage K, Ager A.

Disasters. 2019 Jul 19. doi: 10.1111/disa.12392. [Epub ahead of print]

PMID:
31322750
11.

Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma.

Freeman CL, Kridel R, Moccia AA, Savage KJ, Villa DR, Scott DW, Gerrie AS, Ferguson D, Cafferty F, Slack GW, Farinha P, Skinnider B, Connors JM, Sehn LH.

Blood. 2019 Aug 29;134(9):761-764. doi: 10.1182/blood.2019000258. Epub 2019 Jul 12.

PMID:
31300404
12.

Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.

Mottok A, Hung SS, Chavez EA, Woolcock B, Telenius A, Chong LC, Meissner B, Nakamura H, Rushton C, Viganò E, Sarkozy C, Gascoyne RD, Connors JM, Ben-Neriah S, Mungall A, Marra MA, Siebert R, Scott DW, Savage KJ, Steidl C.

Blood. 2019 Sep 5;134(10):802-813. doi: 10.1182/blood.2019001126. Epub 2019 Jul 10.

PMID:
31292115
13.

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study.

Barraclough A, Alzahrani M, Ettrup MS, Bishton M, van Vliet C, Farinha P, Gould C, Birch S, Sehn LH, Sovani V, Ward MS, Augustson B, Biccler J, Connors JM, Scott DW, Gandhi MK, Savage KJ, El-Galaly T, Villa D, Cheah CY.

Blood Adv. 2019 Jul 9;3(13):2013-2021. doi: 10.1182/bloodadvances.2019000251.

14.

Six years of ecosystem-atmosphere greenhouse gas fluxes measured in a sub-boreal forest.

Richardson AD, Hollinger DY, Shoemaker JK, Hughes H, Savage K, Davidson EA.

Sci Data. 2019 Jul 5;6(1):117. doi: 10.1038/s41597-019-0119-1.

15.

Chronic Pruritus Responding to Dupilumab-A Case Series.

Zhai LL, Savage KT, Qiu CC, Jin A, Valdes-Rodriguez R, Mollanazar NK.

Medicines (Basel). 2019 Jun 29;6(3). pii: E72. doi: 10.3390/medicines6030072.

16.

Keeping Our Finger on the Pulse: Reaffirming the Role of Radiation Therapy in the Curative Management of Early Stage Follicular Lymphoma.

Campbell BA, Plastaras JP, Savage KJ.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):459-465. doi: 10.1016/j.ijrobp.2019.06.2505. Epub 2019 Jun 26. Review. No abstract available.

PMID:
31254657
17.

Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice.

Parquet MDC, Savage KA, Allan DS, Ang MTC, Chen W, Logan SM, Holbein BE.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00855-19. doi: 10.1128/AAC.00855-19. Print 2019 Sep.

PMID:
31209004
18.

Use of dupilumab in patients who are HIV-positive: report of four cases.

Mollanazar NK, Qiu CC, Aldrich JL, Tedaldi E, Valdes-Rodriguez R, Savage KT, Hsu S.

Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18222. [Epub ahead of print] No abstract available.

PMID:
31206599
19.

TNF-α inhibitors in the treatment of hidradenitis suppurativa.

Savage KT, Flood KS, Porter ML, Kimball AB.

Ther Adv Chronic Dis. 2019 May 27;10:2040622319851640. doi: 10.1177/2040622319851640. eCollection 2019. Review.

20.

Higher plasma levels of F2-isoprostanes are associated with slower psychomotor speed in healthy older adults.

Camfield DA, Nolidin K, Savage K, Timmer J, Croft K, Tangestani Fard M, Simpson T, Downey L, Scholey A, Pipingas A, Deleuil S, Stough C.

Free Radic Res. 2019 Apr;53(4):377-386. doi: 10.1080/10715762.2018.1513133. Epub 2019 May 22.

PMID:
31117841
21.

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.

Ramchandren R, Domingo-Domènech E, Rueda A, Trněný M, Feldman TA, Lee HJ, Provencio M, Sillaber C, Cohen JB, Savage KJ, Willenbacher W, Ligon AH, Ouyang J, Redd R, Rodig SJ, Shipp MA, Sacchi M, Sumbul A, Armand P, Ansell SM.

J Clin Oncol. 2019 Aug 10;37(23):1997-2007. doi: 10.1200/JCO.19.00315. Epub 2019 May 21.

PMID:
31112476
22.

Short- and longer-term impacts of Child Friendly Space Interventions in Rwamwanja Refugee Settlement, Uganda.

Metzler J, Diaconu K, Hermosilla S, Kaijuka R, Ebulu G, Savage K, Ager A.

J Child Psychol Psychiatry. 2019 Nov;60(11):1152-1163. doi: 10.1111/jcpp.13069. Epub 2019 May 20.

PMID:
31106415
23.

Child friendly spaces impact across five humanitarian settings: a meta-analysis.

Hermosilla S, Metzler J, Savage K, Musa M, Ager A.

BMC Public Health. 2019 May 15;19(1):576. doi: 10.1186/s12889-019-6939-2.

24.

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients.

Sibon D, Nguyen DP, Schmitz N, Suzuki R, Feldman AL, Gressin R, Lamant L, Weisenburger DD, Rosenwald A, Nakamura S, Ziepert M, Maurer MJ, Bast M, Armitage JO, Vose JM, Tilly H, Jais JP, Savage KJ.

Haematologica. 2019 Apr 19. pii: haematol.2018.213512. doi: 10.3324/haematol.2018.213512. [Epub ahead of print]

25.

Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma.

Biccler JL, Savage KJ, Brown PDN, Jørgensen J, Larsen TS, Poulsen CB, Stoltenberg D, Sehn LH, Scott DW, Gerrie AS, Jakobsen LH, Bøgsted M, El-Galaly TC, Villa D.

Leuk Lymphoma. 2019 Oct;60(10):2516-2523. doi: 10.1080/10428194.2019.1594219. Epub 2019 Apr 3.

PMID:
30943052
26.

Hepatic Lysosomal iNOS Activity Impairs Autophagy in Obesity.

Qian Q, Zhang Z, Li M, Savage K, Cheng D, Rauckhorst AJ, Ankrum JA, Taylor EB, Ding WX, Xiao Y, Cao HJ, Yang L.

Cell Mol Gastroenterol Hepatol. 2019;8(1):95-110. doi: 10.1016/j.jcmgh.2019.03.005. Epub 2019 Mar 27.

27.

Reply to: "Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment".

Savage KT, Flood KS, Popatia S, Golbari NM, Salian P, Kimball AB, Porter ML.

J Am Acad Dermatol. 2019 Jul;81(1):e19-e20. doi: 10.1016/j.jaad.2019.03.051. Epub 2019 Mar 23. No abstract available.

PMID:
30914340
28.

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.

Hapgood G, Ben-Neriah S, Mottok A, Lee DG, Robert K, Villa D, Sehn LH, Connors JM, Gascoyne RD, Feldman AL, Farinha P, Steidl C, Scott DW, Slack GW, Savage KJ.

Br J Haematol. 2019 Aug;186(3):e28-e31. doi: 10.1111/bjh.15860. Epub 2019 Mar 14. No abstract available.

PMID:
30873584
29.

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas.

Ellin F, Maurer MJ, Srour L, Farooq U, Jerkeman M, Connors JM, Smedby KE, Bennani NN, Ansell SM, Slack GW, Cerhan JR, Relander T, Feldman AL, Savage KJ.

Br J Haematol. 2019 Aug;186(3):e24-e27. doi: 10.1111/bjh.15859. Epub 2019 Mar 11. No abstract available.

PMID:
30859549
30.

Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.

Liberante FG, Lappin K, Barros EM, Vohhodina J, Grebien F, Savage KI, Mills KI.

Sci Rep. 2019 Feb 25;9(1):2678. doi: 10.1038/s41598-019-39591-7.

31.

ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA.

Gilmore AR, Alderdice M, Savage KI, O'Reilly PG, Roddy AC, Dunne PD, Lawler M, McDade SS, Waugh DJ, McArt DG.

Cancer Res. 2019 Apr 15;79(8):2072-2075. doi: 10.1158/0008-5472.CAN-18-1976. Epub 2019 Feb 13.

PMID:
30760519
32.

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition.

Ennishi D, Takata K, Béguelin W, Duns G, Mottok A, Farinha P, Bashashati A, Saberi S, Boyle M, Meissner B, Ben-Neriah S, Woolcock BW, Telenius A, Lai D, Teater M, Kridel R, Savage KJ, Sehn LH, Morin RD, Marra MA, Shah SP, Connors JM, Gascoyne RD, Scott DW, Melnick AM, Steidl C.

Cancer Discov. 2019 Apr;9(4):546-563. doi: 10.1158/2159-8290.CD-18-1090. Epub 2019 Jan 31.

PMID:
30705065
33.

Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial.

Sarris J, Byrne GJ, Stough C, Bousman C, Mischoulon D, Murphy J, Macdonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng CH.

J Affect Disord. 2019 Feb 15;245:1007-1015. doi: 10.1016/j.jad.2018.11.092. Epub 2018 Nov 13.

PMID:
30699842
34.

Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".

Savage KA, Parquet MDC, Allan DS, Davidson RJ, Holbein BE, Lilly EA, Fidel PL Jr.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e02508-18. doi: 10.1128/AAC.02508-18. Print 2019 Feb. No abstract available.

35.

Increases in total cholesterol and low density lipoprotein associated with decreased cognitive performance in healthy elderly adults.

Stough C, Pipingas A, Camfield D, Nolidin K, Savage K, Deleuil S, Scholey A.

Metab Brain Dis. 2019 Apr;34(2):477-484. doi: 10.1007/s11011-018-0373-5. Epub 2019 Jan 16.

PMID:
30649667
36.

Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma.

Ramchandren R, Advani RH, Ansell SM, Bartlett NL, Chen R, Connors JM, Feldman T, Forero-Torres A, Friedberg JW, Gopal AK, Gordon LI, Kuruvilla J, Savage KJ, Younes A, Engley G, Manley TJ, Fenton K, Straus DJ.

Clin Cancer Res. 2019 Mar 15;25(6):1718-1726. doi: 10.1158/1078-0432.CCR-18-2435. Epub 2019 Jan 7.

PMID:
30617130
37.

Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment.

Campbell AM, Morris M, Gallagher R, Boyd R, Carson H, Harkin DP, Wielogorska E, Elliott C, Savage KI, McIntosh SA.

BMJ Open. 2018 Dec 22;8(12):e023115. doi: 10.1136/bmjopen-2018-023115.

38.

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, Rushton C, Tang J, Thomas N, Slack GW, Farinha P, Takata K, Miyata-Takata T, Craig J, Mottok A, Meissner B, Saberi S, Bashashati A, Villa D, Savage KJ, Sehn LH, Kridel R, Mungall AJ, Marra MA, Shah SP, Steidl C, Connors JM, Gascoyne RD, Morin RD, Scott DW.

J Clin Oncol. 2019 Jan 20;37(3):190-201. doi: 10.1200/JCO.18.01583. Epub 2018 Dec 3.

PMID:
30523716
39.

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group.

Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Erratum in: Lancet. 2019 Jan 19;393(10168):228.

PMID:
30522922
40.

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.

Ascierto PA, Long GV, Robert C, Brady B, Dutriaux C, Di Giacomo AM, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebbé C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Ny L, Arance A, Svane IM, Schadendorf D, Gogas H, Saci A, Jiang J, Rizzo J, Atkinson V.

JAMA Oncol. 2019 Feb 1;5(2):187-194. doi: 10.1001/jamaoncol.2018.4514. Erratum in: JAMA Oncol. 2019 Feb 1;5(2):271.

41.

Training Toward a Movement: Career Development Insights From the First 7 Years of a Global Health Equity Residency.

Palazuelos D, Dhillon R, Nelson AK, Savage KP, Conover R, Katz JT, Rhatigan JJ.

J Grad Med Educ. 2018 Oct;10(5):509-516. doi: 10.4300/JGME-D-18-00213.1.

42.

High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology.

Chong LC, Ben-Neriah S, Slack GW, Freeman C, Ennishi D, Mottok A, Collinge B, Abrisqueta P, Farinha P, Boyle M, Meissner B, Kridel R, Gerrie AS, Villa D, Savage KJ, Sehn LH, Siebert R, Morin RD, Gascoyne RD, Marra MA, Connors JM, Mungall AJ, Steidl C, Scott DW.

Blood Adv. 2018 Oct 23;2(20):2755-2765. doi: 10.1182/bloodadvances.2018023572.

43.

Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease Progression.

Stupnikov A, O'Reilly PG, McInerney CE, Roddy AC, Dunne PD, Gilmore A, Ellis HP, Flannery T, Healy E, McIntosh SA, Savage K, Kurian KM, Emmert-Streib F, Prise KM, Salto-Tellez M, McArt DG.

JCO Precis Oncol. 2018 Sep 13;2. doi: 10.1200/PO.18.00014.

44.

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.

Reiman T, Savage KJ, Crump M, Cheung MC, MacDonald D, Buckstein R, Couban S, Piliotis E, Imrie K, Spaner D, Shivakumar S, Kuruvilla J, Villa D, Shepherd LE, Skamene T, Winch C, Chen BE, Hay AE.

Leuk Lymphoma. 2019 Apr;60(4):912-919. doi: 10.1080/10428194.2018.1515937. Epub 2018 Oct 10.

PMID:
30301414
45.

Using Scipion for stream image processing at Cryo-EM facilities.

Gómez-Blanco J, de la Rosa-Trevín JM, Marabini R, Del Cano L, Jiménez A, Martínez M, Melero R, Majtner T, Maluenda D, Mota J, Rancel Y, Ramírez-Aportela E, Vilas JL, Carroni M, Fleischmann S, Lindahl E, Ashton AW, Basham M, Clare DK, Savage K, Siebert CA, Sharov GG, Sorzano COS, Conesa P, Carazo JM.

J Struct Biol. 2018 Dec;204(3):457-463. doi: 10.1016/j.jsb.2018.10.001. Epub 2018 Oct 5.

46.

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.

Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E, Braziel RM, Delabie J, Weisenburger DD, Song JY, Chan WC, Cook JR, Fu K, Greiner T, Smeland E, Holte H, Savage KJ, Glinsmann-Gibson BJ, Gascoyne RD, Staudt LM, Jaffe ES, Connors JM, Scott DW, Steidl C, Rimsza LM.

Blood. 2018 Nov 29;132(22):2401-2405. doi: 10.1182/blood-2018-05-851154. Epub 2018 Sep 26.

PMID:
30257882
47.

Annular Lesions: Diagnosis and Treatment.

Trayes KP, Savage K, Studdiford JS.

Am Fam Physician. 2018 Sep 1;98(5):283-291. Review.

48.

Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.

Chihara D, Wong S, Feldman T, Fanale MA, Sanchez L, Connors JM, Savage KJ, Oki Y.

Hematol Oncol. 2019 Feb;37(1):35-38. doi: 10.1002/hon.2560. Epub 2018 Oct 23.

PMID:
30209819
49.

High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.

Tsang ES, Villa D, Loscocco F, Visani G, Power M, Guiducci B, Clissa C, Song K, Toze C, Abou Mourad Y, Sutherland H, Sanford D, Nantel SH, Sehn LH, Scott DW, Savage KJ, Connors JM, Gerrie AS, Isidori A.

Bone Marrow Transplant. 2019 Mar;54(3):481-484. doi: 10.1038/s41409-018-0328-9. Epub 2018 Aug 31. No abstract available.

PMID:
30171222
50.

Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro.

Parquet MDC, Savage KA, Allan DS, Davidson RJ, Holbein BE.

Front Microbiol. 2018 Aug 14;9:1811. doi: 10.3389/fmicb.2018.01811. eCollection 2018.

Supplemental Content

Loading ...
Support Center